Showing results (481-490 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|March 8, 2006
Aromatase inhibitors in breast cancer: a review of cost considerations and cost effectivenessJonathan KarnonPharmacoeconomics|March 8, 2006
Trends in outpatient prescription drug use and related costs in the US: 1998-2003Diane K Wysowski, Laura A Governale, Joslyn SwannPharmacoeconomics|January 4, 2026
Developing and Calibrating a Colorectal Cancer Microsimulation Model for Northern IrelandOlivia Adair, Ethna McFerran, Mark Lawler, et al.Pharmacoeconomics|November 23, 2016
Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?Brendan Mulhern, Richard Norman, Paula Lorgelly, et al.Pharmacoeconomics|October 23, 2016
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBenjamin Kearns, Abdullah Pandor, Matt Stevenson, et al.Pharmacoeconomics|April 22, 2004
The economic burden of allergic rhinitis: a critical evaluation of the literatureShelby D Reed, Todd A Lee, Douglas C McCroryPharmacoeconomics|April 22, 2004
Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancerGeorge Dranitsaris, Julia Elia-Pacitti, Wayne CottrellPharmacoeconomics|May 13, 2004
Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?Patricia D BrownPharmacoeconomics|May 13, 2004
Management and costs of treating lung cancer patients in a university hospitalKonstantin J Dedes, Thomas D Szucs, Stephan Bodis, et al.Pharmacoeconomics|July 15, 2004
Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD)Mitchell Friedman, Shailendra S Menjoge, Susan F Anton, et al.Pageof 335